Key Takeaways
-
Dental practice valuations in 2026 commonly use three frameworks: percentage of collections for smaller private sales, normalized EBITDA multiples for DSO and institutional buyers, and platform multiples for large multi-location groups. Each framework can produce very different values for the same practice.
-
The earnings base usually matters more than the multiple. A CPA-led valuation builds Normalized Adjusted EBITDA by normalizing owner compensation, documenting add-backs, and cross-referencing production, collections, and tax data so the number can withstand buyer review.
-
Owner dependency can trigger a 10–40% discount. Practices where the owner produces more than 50% of revenue often face lower multiples, fewer qualified buyers, and earnout requirements unless an associate is added well before transition.
-
Private-buyer and DSO offers can differ by hundreds of thousands to millions. Private buyers tend to anchor to collections, while DSOs pay a multiple of normalized EBITDA and often include a meaningful equity component that requires careful evaluation.
-
McLerran & Associates delivers diligence-grade, side-by-side valuations for both private-buyer and DSO markets, runs a competitive auction process, and reports an 85–90% transaction rate with roughly 30% higher average outcomes than owners selling independently.
Start a confidential discovery call with McLerran & Associates.
The Three 2026 Valuation Frameworks And How To Know Which One Applies
Three primary frameworks are used to value dental practices in 2026. The right one depends on practice size, profitability, and the likely buyer pool.
Percentage-of-collections valuation expresses value as a percentage of annual gross revenue. It is most common in doctor-to-doctor transactions, especially for smaller practices where an individual dentist uses a bank loan. Private Practice Research May 2026 report on dental practice valuation places the general range for private sales at 65 to 85 percent of annual gross collections. Practices with high overhead, owner-dependent production, or declining revenue tend to fall near the lower end. Associate-driven, growing, metropolitan practices tend to land near the upper end.
EBITDA multiple valuation uses EBITDA, which stands for earnings before interest, taxes, depreciation, and amortization. EBITDA is a common measure of operating cash flow. This framework dominates DSO and private equity transactions. Buyers in this category focus on normalized, transferable earnings rather than revenue. The basic formula is: Practice Value equals Adjusted EBITDA times Market Multiple. The multiple depends on scale, buyer type, and quality factors.
Platform multiple valuation applies when a practice or group is large enough to serve as the foundation of a new DSO. This usually requires roughly $3 million to $5 million or more in normalized EBITDA, with $5 million-plus commonly cited as the platform-grade threshold. These groups also tend to have enterprise-grade infrastructure such as centralized management, multi-location operations, and non-owner leadership. At this level, private equity buyers price the asset as a scalable business rather than only a clinical operation.
The table below maps practice profile to valuation method and typical 2026 range. These are illustrative ranges drawn from current market data, not guarantees of any specific outcome. Consult your own advisors before making any financial decisions.
|
Practice Profile |
Primary Valuation Method |
Typical 2026 Range |
Why This Method Applies |
|---|---|---|---|
|
Solo practice under $1.5 million collections |
Percentage of collections |
Owner compensation often distorts clean cash flow reporting, and the buyer is typically another dentist using bank financing. |
|
|
Single-location or small group with $1.5 million plus collections |
Normalized Adjusted EBITDA multiple |
5 to 8 times EBITDA |
Institutional and DSO interest rewards verifiable margins. Collections-based pricing becomes unreliable as overhead and associate costs vary. |
|
Multi-location group with $5 million plus EBITDA |
Platform EBITDA multiple |
9 to 14 times EBITDA |
Private equity consolidators often pay a premium for turnkey infrastructure, non-owner management layers, and scalable systems. |
How a CPA-Led Dental Practice Valuation Is Actually Built
The earnings base the multiple is applied to usually matters more than the multiple itself. A diligence-grade valuation builds that earnings base from the ground up, line by line.
Step 1: Pull and cross-reference the data. A rigorous valuation begins by remotely accessing the practice management software, pulling production and collections reports by provider and procedure code, and cross-referencing them against tax returns and financial statements. This step catches gaps between what the practice bills, what it collects, and what the financials show. Buyers will find these gaps during due diligence if the seller does not identify them first.
Step 2: Normalize owner compensation. The owner-dentist’s compensation is almost always the largest single adjustment in a dental practice valuation. To normalize it, the owner’s actual pay is removed from the expense base and replaced with a market-rate replacement cost, meaning what it would cost to hire a clinical dentist to perform the same work.
Step 3: Identify and document add-backs. An add-back is an expense in the financials that a new owner genuinely will not incur. That expense is added back to reported profit to arrive at transferable earnings. Common defensible add-backs include personal vehicle expenses, owner life insurance premiums, above-market family payroll, one-time legal fees, and personal continuing education costs. Unsupported add-backs are often removed during diligence and can create broader skepticism about the entire earnings presentation.
Step 4: Arrive at Normalized Adjusted EBITDA. The result of steps 1–3 is Normalized Adjusted EBITDA, which reflects sustainable operating cash flow under new ownership. This is the number that gets multiplied. A worked example illustrates the impact. Consider a practice with $300,000 in base EBITDA. The owner pays themselves $420,000 against a $250,000 fair-market replacement rate, and the practice has $20,000 in personal auto expenses. These adjustments produce $190,000 in normalized add-backs, bringing Adjusted EBITDA to $490,000. At a 5–7x multiple, that yields an estimated value of $2.45M–$3.43M.
A weak or “free” valuation often skips or shortcuts these steps. When a buyer’s quality-of-earnings team, the forensic accountants who examine every number after a letter of intent is signed, finds add-backs that cannot be documented or an EBITDA base that does not hold up, the deal is frequently re-traded. The agreed price can drop by hundreds of thousands of dollars at the point when the seller has the least negotiating leverage.
The Owner-Dependency Discount And How To Reduce It
Provider dependency, meaning the degree to which revenue is concentrated in a single producing dentist, can be one of the most consequential variables in dental practice valuation. A practice where the owner personally generates the large majority of clinical revenue carries meaningful transition risk. If patients came primarily because of that specific dentist, revenue may decline after the sale closes.
Private Practice Research 2026 data brief on owner-dependence reports that practices where a single provider produces more than 90 percent of total production transact at roughly 10 to 20 percent below comparably sized owner-independent practices on a multiple basis. When buyer-pool reduction is included, meaning DSO buyers who decline to bid at all on heavily owner-dependent practices, the effective discount can widen to roughly 25 to 40 percent.
The discount operates through two mechanisms. Buyers may apply a lower multiple or reduce the EBITDA base to reflect post-close revenue risk. At the same time, the competitive bidding process that pushes prices higher often does not materialize when fewer buyers view the practice as a viable acquisition target.
The discount can often be reduced. Institutional buyers tend to use provider concentration benchmarks when they screen a practice. A founding dentist producing below 35 percent of collections usually triggers minimal concern. Production above 50 percent often triggers earnout provisions and extended post-close employment requirements. One of the most effective ways to reduce the discount is to bring an associate into the practice 3 to 5 years before a planned transition. That timing allows patient relationships to transfer and associate production to appear in the trailing 24 to 36 months of practice management data that buyers audit. An associate hired only a few months before listing usually does not show the relationship-transfer history that buyers price.
Why the Same Practice Gets Two Different Valuations: Private Buyer Vs. Dental Service Organization
The arithmetic behind private-buyer and DSO valuations is genuinely different. Negotiating style alone does not explain the gap. Consider a hypothetical general dental practice collecting $2 million annually, with a normalized adjusted EBITDA of $400,000, which reflects a 20 percent margin, and an owner who produces approximately 60 percent of clinical revenue.
To a private buyer, an individual dentist using a bank loan, the valuation is anchored to collections. Private Practice Research 2026 framework places general practice private-sale ranges at 65 to 85 percent of collections, implying a value of $1.3 million to $1.7 million for this practice. The private buyer often views the deal as buying their own future production and their job. Owner dependency matters, but it is usually reflected through the multiple and deal structure rather than eliminating the buyer.
To a DSO or institutional buyer, the same practice is valued on normalized EBITDA. At a 5 to 7 times multiple on $400,000 of EBITDA, the indicated value is $2.0 million to $2.8 million. That creates a gap of $300,000 to $1.5 million on the same operation with no change to the underlying practice. Private Practice Research 2026 report notes a 40 to 80 percent DSO premium over private-buyer pricing on comparable practices.
The DSO offer is usually a mix of cash and equity. Up to roughly 40 percent of a DSO deal can be paid in equity rather than cash at closing. In that case, the seller is effectively investing in the DSO platform and realizes that portion of value only at a future recapitalization or sale, typically 3 to 7 years later. Equity can be structured at the joint-venture level, which offers ongoing distributions and a higher floor but a lower ceiling, or at the holding-company level, which offers no distributions but a higher potential ceiling if the platform performs. JV, HoldCo, and hybrid equity structures are being used as strategic levers in DSO deals, which makes structure literacy important for sellers comparing offers.
McLerran & Associates works both the private-buyer and DSO paths in roughly equal measure, splitting transactions approximately 50/50 between the two. This approach supports a true side-by-side valuation that quantifies what a practice may be worth in both markets.
Compare private-buyer and DSO values for your practice.
Overhead Discipline And the 50-40-30 Rule
Overhead discipline can be one of the practice-level factors that most reliably moves a valuation. A common benchmark is the 50-40-30 rule. Solo practices aim to keep overhead at no more than 50 percent of collections, small groups at 40 percent, and mature DSO platforms at 30 percent. This rule works as a broad profitability screen rather than a precise valuation formula, because it does not adjust for owner compensation normalization or buyer-specific efficiencies.
In a transaction context, the rule serves as a quick signal of overhead discipline. A practice operating near 30 percent platform overhead can often expect valuations at or above 10 times EBITDA. A practice at 45 to 50 percent overhead usually attracts more conservative bids. A 5-point overhead reduction on a group generating $10 million in collections adds $500,000 to normalized EBITDA. At a 10 times multiple, that translates to $5 million in additional value.
What Moves the Number in 2026
Several market-level and practice-level factors can shape dental practice valuations in 2026.
On the market side, 69 percent of surveyed DSOs indicated their private equity sponsors expect a moderate or high increase in 2026 acquisition activity. The same survey notes that 78 percent anticipate a recapitalization within 12 to 36 months, which can create urgency among buyers that benefits prepared sellers. Headline EBITDA multiples have held steady for two consecutive years, while the spread between the best and middle-tier offers on any given practice has widened. That widening spread makes a competitive process more valuable.
The current interest-rate environment tends to affect private buyers more directly than DSOs. Individual dentists using bank loans face higher debt-service costs, which can compress what they are willing to pay. Platform multiples have also compressed relative to 2021 peaks as capital markets have normalized.
At the practice level, several factors often move the number in a consistent way:
-
Hygiene economics: Hygiene production at 30 to 35 percent of total production is often identified as a multiple driver. This level signals recurring patient demand and a healthier restorative pipeline.
-
Overhead discipline: Practices with lower overhead relative to collections usually produce higher EBITDA margins. Higher margins tend to attract stronger multiples and a broader buyer pool.
-
Payer mix: Fee-for-service and in-network PPO revenue are often valued most favorably. Significant Medicaid concentration can suppress multiples and restrict the buyer pool, especially given the expectation that reduced federal Medicaid funding will pressure states to cut adult dental benefits beginning October 1, 2026.
-
Provider dependency: As discussed above, owner production share can be one of the clearest multiple drivers in either direction.
-
Revenue durability: Buyers test whether EBITDA reflects durable operating performance or temporary conditions such as deferred equipment replacement, open staff positions, or reduced marketing spend.
What a “Free” Valuation Gets Wrong
A free valuation is almost always a lead magnet, meaning a back-of-the-napkin number designed to start a conversation rather than survive buyer scrutiny. The real problem is that the number becomes an anchor. Once an owner internalizes a valuation figure, it shapes every later conversation, including the one where a buyer’s quality-of-earnings team challenges it.
A valuation calculator’s output is only as strong as the assumptions entered. Dental practice valuation requires buyer judgment around add-back support, owner dependence, hygiene stability, provider continuity, payer mix, working capital, and deal structure. A free tool or a quick estimate from a generalist broker usually skips many of these inputs.
When a weak valuation goes to market, two common outcomes appear. Some practices attract buyers who quickly see the gap between the stated value and the defensible value and then re-trade the deal after exclusivity is signed, when the seller has limited leverage. Other practices fail to attract serious institutional buyers because the earnings presentation does not hold up to initial screening.
Diligence-grade, CPA-led work done before the practice goes to market can prevent this pattern. Every add-back is documented and defensible before the first buyer conversation. The EBITDA figure that goes into the market is usually the same one that comes out the other side of due diligence.
What To Do Before You Get a Valuation
A few preparation steps can strengthen a valuation and reduce the risk of late-stage re-trading:
-
Gather 3 years of financial statements, tax returns, and practice management software reports. Buyers often audit at least this far back.
-
Document every discretionary and non-recurring expense with the underlying invoice, payroll record, or mileage log. Verbal explanations rarely survive diligence.
-
Clarify owner compensation and role, including what the owner is paid, what clinical work they perform, and what a market-rate replacement would cost.
-
Review associate employment agreements for current, enforceable non-solicitation provisions and clearly defined compensation structures.
-
Define your “why” before any buyer conversation, whether that is clinical autonomy, staff protection, partial liquidity, or a full exit, because the right path and buyer depend on that goal.
Why McLerran & Associates
McLerran & Associates is a dental-specific sell-side M&A advisory and brokerage firm and one of the few that runs both transition paths in roughly equal measure. The firm has completed roughly 2,000 successful practice sales, closed approximately $2 billion in transaction volume, and evaluated more than 10,000 practices over roughly 35 years in business. Its transaction rate of roughly 85 to 90 percent compares to an industry norm closer to 35 to 40 percent.
Every McLerran engagement begins with a comprehensive, CPA-led EBITDA analysis. This diligence-grade work is done up front so the numbers hold up when buyers scrutinize them and the deal is less likely to be renegotiated down later. For owners weighing both paths, McLerran delivers a side-by-side valuation that quantifies a practice’s potential value in both the private-buyer and DSO markets.
From that foundation, McLerran creates competition. The firm runs a structured, auction-like process among a vetted pool of well-qualified buyers, typically generating around 10 offers within 45 to 60 days on DSO transactions. Poorly performing buyers are screened out before they reach the table. Clients often achieve roughly 30 percent higher valuations on average than owners selling on their own.
McLerran is sell-side only and never represents the buyer. Its incentives remain aligned with the practice owner from the first valuation conversation through closing.
Discuss a CPA-led valuation and sale process.
Frequently Asked Questions
How Is a Dental Practice Valued?
A dental practice is typically valued using one of three primary methods depending on its size and likely buyer. Smaller practices sold to individual dentists are often valued as a percentage of annual gross collections, as described earlier. Practices with $1.5 million or more in collections that attract DSO or institutional buyers are usually valued on a multiple of Normalized Adjusted EBITDA, which reflects operating earnings after owner compensation is reset to market rate and non-recurring expenses are added back. Large multi-location groups with $5 million or more in EBITDA may qualify for platform multiples. Across methods, building a defensible EBITDA figure can be one of the most important steps, because the multiple is applied to that number.
Should I Sell to a Private Buyer or a DSO?
The right path often depends on practice size, profitability, and personal goals. Smaller premier practices around $1–1.5 million in revenue can fit a doctor-to-doctor sale well. Larger practices, particularly those with $1.5 million or more in revenue, are typically eligible for DSO consideration, which can produce a higher headline value. Practices in the $1.5–3 million revenue range can often go either direction. Many owners find it helpful to see a side-by-side comparison of what the practice may be worth in both markets rather than relying on a single unsolicited offer.
Why Pay for a Valuation When Others Are Free?
As discussed earlier, a free valuation is typically a lead magnet that may not survive buyer scrutiny. The key point is that a CPA-led, diligence-grade valuation documents each adjustment and builds an earnings figure designed to hold up under examination. The cost of a weak valuation often shows up as the gap between the number that goes to market and the number that survives diligence.
Are Dental Service Organization Deals All Cash?
Most DSO transactions use a mix of cash and contingent components. A typical structure combines cash at closing, equity rollover, and an earnout tied to post-close performance targets. Equity can be structured at the joint-venture level with ongoing distributions and a higher floor but lower ceiling, or at the holding-company level, where there are no distributions but the potential upside is higher if the platform performs well at a future recapitalization. Up to roughly 40 percent of a DSO deal can be paid in equity rather than cash, which is why evaluating the DSO’s financial health, management quality, and private equity backing can matter as much as evaluating the headline multiple. Earnout provisions typically add 5 to 20 percent of additional value but introduce measurement risk if post-close operational decisions affect the metrics.
Do I Have To Keep Working After I Sell?
In a DSO transaction, a post-close employment commitment is standard. A minimum 5-year working agreement has become more common as buyers prioritize clinical continuity. The length and terms of that commitment are negotiable and form a meaningful part of the total economic package. In a private doctor-to-doctor walk-away sale, the seller typically works back only 4 to 8 weeks before exiting. Some larger practices support a partnership or vest-out structure, where the owner sells approximately 50 percent now to a future partner who buys the remaining share over time.
Is Now a Good Time To Sell?
Demand for premier, well-documented practices remains strong, and valuations for Class A assets sit near historic highs. DSO acquisition activity is projected to increase in 2026, with a high-demand, low-supply environment for premium practices. The market is not uniform, however. Practices with heavy Medicaid exposure, significant owner dependency, or documentation gaps may face more conservative underwriting. A comprehensive valuation can help determine whether a specific practice is positioned to attract the right buyers at the right price. Owners who are not yet ready to sell can often revisit the valuation a year later rather than feeling pushed into a deal before the timing fits.
Conclusion: Dental Practice Valuation in 2026 Is a Method Decision
Dental practice valuation in 2026 functions as a method decision as much as a number. The framework applied, the earnings base constructed, the add-backs documented, and the buyer pool engaged can all influence what an owner ultimately receives. The difference between a defensible valuation and a quick estimate can reach seven figures for larger practices.
McLerran & Associates builds diligence-grade, CPA-led valuations that shape the narrative around EBITDA, produces side-by-side private-buyer and DSO valuations so owners choose their path with fuller information, and runs a structured, competitive process that creates the buyer tension needed to improve outcomes. With roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and a transaction rate of roughly 85–90%, the firm sells practices rather than merely listing them.
This article is intended as education only and does not constitute investment, tax, or legal advice. Consult your own advisors before making any financial decisions related to a practice transition.
Find out what your practice may be worth with a comprehensive valuation.
